EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis

Berna Akıncı Özyürek iD, Kerem Ensarioğlu iD, Tuğçe Şahin Özdemirel iD, Esma Sevil Akkurt iD, Özlem Özdağ iD, Esma Zenbilli iD

Turkish Journal of Medical Sciences · 18.10.2024 · 54 (5) · 900-907

DOI: 10.55730/1300-0144.5866 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.10.2024. Verfasst von Berna Akıncı Özyürek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Disease, Atatürk Sanatorium Research and Training Hospital, University of Health Sciences, Ankara, Turkiye. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Pyridones, Antifibrotic Agents, Disease Progression. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) are two entities categorized fibrotic lung diseases. With a similar clinical presentation and treatment modalities in many cases, the line differentiating two diseases may not be evident. We aimed to evaluate the effectiveness of antifibrotic treatment and the course of fibrotic lung diseases. Material and Methods: The study included patients diagnosed with IPF and PPF who were given antifibrotic treatment and followed up for one year in our clinic. At one year, treatment response and radiological evaluation were investigated by high-resolution computed tomography.

Results

Eighty-seven patients were included in the study (57 with IPF and 30 with PPF). Under antifibrotic treatment, there were no statistically significant losses in 6MWT, FVC, and DLCO values at the 6-month and 12-month evaluations. The most common side effects were photosensitivity for patients under the pirfenidone regimen, while diarrhea was predominantly observed in the PPF group. Radiological progression was observed in 22.9% of all patients at the yearly evaluation. Hospitalization requirements were more evident in the PPF group, with at least one hospitalization history present in 60% (n=18) of patients compared to 12.3% (n=7) of IPF patients.

Conclusion

A personalized approach is preferred with similar clinical profiles for both treatment modalities, with specific side effects considered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisPyridonesAntifibrotic AgentsDisease ProgressionHumansMaleFemaleAgedMiddle AgedTreatment OutcomeTomography, X-Ray ComputedPulmonary FibrosisLungVital Capacity

Stichwörter der Autor:innen

Idiopathic pulmonary fibrosisantifibrotic treatmentprognosisprogressionprogressive pulmonary fibrosis

Substanzen

pirfenidonePyridonesAntifibrotic Agents

Autor:innen und Institutionen

  • Department of Chest Disease, Atatürk Sanatorium Research and Training Hospital, University of Health Sciences, Ankara, Turkiye.

ORCID-Profile: Berna Akıncı Özyürek, Kerem Ensarioğlu, Tuğçe Şahin Özdemirel, Esma Sevil Akkurt, Özlem Özdağ, Esma Zenbilli

Zitieren

APA

Özyürek, B. A., Ensarioğlu, K., Özdemirel, T. Ş., Akkurt, E. S., Özdağ, Ö., & Zenbilli, E. (2024). Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. Turkish Journal of Medical Sciences, 54(5), 900-907. https://doi.org/10.55730/1300-0144.5866

Vancouver

Özyürek BA, Ensarioğlu K, Özdemirel TŞ, Akkurt ES, Özdağ Ö, Zenbilli E. Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. Turkish Journal of Medical Sciences. 2024;54(5):900-907. doi:10.55730/1300-0144.5866

BibTeX
@article{zyrek2024,
  author = {Özyürek, Berna Akıncı and Ensarioğlu, Kerem and Özdemirel, Tuğçe Şahin and Akkurt, Esma Sevil and Özdağ, Özlem and Zenbilli, Esma},
  title = {Antifibrotic treatment response comparison of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis},
  journal = {Turkish Journal of Medical Sciences},
  year = {2024},
  volume = {54},
  number = {5},
  pages = {900--907},
  doi = {10.55730/1300-0144.5866}
}
Kostenlos starten →